That spike in the summer didn't happen for no reason at all. I think people are getting the message.

Science is a contact sport. People think about it being genteel, but it's a tough game.

We need people to fill out all the fields in a meaningful fashion. Everyone ought to know what's going on.

For this reason, while we believe that many more people could benefit from taking aspirin, it is important for patients and their physicians to discuss this issue and weigh the benefits and potential drawbacks of this therapy.

The good news is that there's been a lot of compliance with requirements in terms of trial registration. It's good progress and we're encouraged by that, but there's a long way to go.

For this reason, while we believe that many more people could benefit from taking aspirin, it is important for patients and their physicians to discuss the issue and weigh the benefits and potential drawbacks to this therapy.